Women s Interagency HIV Study (WIHS) IV, Limited Competition (U01)

The summary for the Women s Interagency HIV Study (WIHS) IV, Limited Competition (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Women s Interagency HIV Study (WIHS) IV, Limited Competition (U01): -This limited competition RFA solicits applications to continue projects currently funded at the seven sites for the Women s Interagency HIV Study (WIHS) for a 5-year period beginning November 1, 2007. The WIHS is a multi-site prospective epidemiology cohort study of women in the United States who are either infected with HIV or at increased risk for such infections. The WIHS cohort was established in 1994 and has participated in follow-up visits at six-month intervals since that time. The study is currently funded by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Child Health and Human Development (NICHD), the National Institute on Drug Abuse (NIDA) and the National Cancer Institute (NCI). Due to the longitudinal data collected and need for continuing follow-up, competition will be restricted to the seven current WIHS institutions. -The specific objective and scope for continuing the WIHS Study is to address research questions on the natural and treated history of HIV infection in a representative cohort of women in the United States as well as emerging questions concerning HIV infection and treatment. The WIHS, by prospectively studying a cohort of predominantly minority women with or at high risk for HIV infection, is providing detailed information relevant to the evolving biological and psychosocial characteristics of the HIV/AIDS epidemic in U.S. women as we move into a second decade of antiretroviral therapy. -This RFA will use the U01 (Cooperative Agreement) mechanism.
Federal Grant Title: Women s Interagency HIV Study (WIHS) IV, Limited Competition (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Income Security and Social Services Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-07-004
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.27993.393
CFDA Descriptions: Drug Abuse and Addiction Research Programs 93.393 Cancer Cause and Prevention Research
Current Application Deadline: No deadline provided
Original Application Deadline: Mar 14, 2007
Posted Date: Dec 27, 2006
Creation Date: Dec 27, 2006
Archive Date: Apr 13, 2007
Total Program Funding: $20,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 7
Cost Sharing or Matching: 93.394 -- Cancer Detection and Diagnosis Research
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Applications may be submitted by the seven awardees  the current six WIHS clinical sites and the WIHS Data Management and Analysis Center (WDMAC). The seven cooperative agreement numbers, geographic locations, principal investigators, and awardee institutions are: WIHS Clinical Sites: U01 AI 35004, Bronx, NY (PI: Dr. Kathryn Anastos, Montefiore Medical Center) U01 AI 31834, Brooklyn, NY (PI: Dr. Howard Minkoff, SUNY Downstate Medical Center) U01 AI 34993, Chicago, IL (PI: Dr. Mardge Cohen, Hektoen Institute for Medical Research) U01 HD 32632, Los Angeles, CA (PI: Dr. Alexandra Levine, University of Southern California) U01 AI 34989, San Francisco, CA (PI: Dr. Ruth Greenblatt, University of California San Francisco) U01 AI 34994, Washington, DC (PI: Dr. Mary Young, Georgetown University) WIHS Data Management and Analysis Center (WDMAC): U01 AI 42590, Baltimore, MD, (PI: Dr. Stephen Gange, Johns Hopkins University)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2019 FederalGrants.com